Kaufman Rossin Wealth’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,360
Closed -$279K 131
2025
Q4
$279K Buy
6,360
+1,000
+19% +$41.4K 0.15% 115
2025
Q3
$221K Sell
5,360
-1,031
-16% -$41.4K 0.12% 135
2025
Q2
$282K Sell
6,391
-895
-12% -$35.8K 0.18% 89
2025
Q1
$269K Buy
+7,286
New +$260K 0.19% 105

Other funds holding EXEL

Kaufman Rossin Wealth's EXEL Position: Q1 2026 in Review

Kaufman Rossin Wealth sold out of Exelixis (EXEL) in Q1 2026, closing a stake of 6,360 shares — an estimated $279K sold.

Kaufman Rossin Wealth first reported a position in EXEL in Q1 2025 and held it in 4 quarters. The position peaked at $282K in Q2 2025. 695 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Kaufman Rossin Wealth reported no remaining Exelixis position as of Q1 2026 after selling out during the quarter.
  • Kaufman Rossin Wealth sold 6,360 Exelixis shares in Q1 2026, an estimated $279K.
  • Kaufman Rossin Wealth first reported a position in Exelixis in Q1 2025 and held it in 4 quarters.
  • Kaufman Rossin Wealth's Exelixis position peaked at $282K in Q2 2025.
  • 695 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Kaufman Rossin Wealth's 13F filing for Q1 2026, filed 17 Apr 2026.